- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04223115
A Randomized Controlled Study of Digitalized Cognitive Behavioral Intervention for Antenatal Depression
February 16, 2024 updated by: Andre Sourander, University of Turku
Randomized Controlled Trial of Digitalized Cognitive Behavioral Therapy With Telephone Coaching for Mothers Suffering From Depression During Pregnancy
The main objective of the current research project is to evaluate the effectiveness of the digitalized cognitive behavioral therapy program including telephone coaching for antenatal depressive symptoms.
The participants are screened from the general population of pregnant women, as a part of the routine maternity health care check-ups.
Mothers with depressive symptoms will be randomized into intervention group receiving guided digitalized treatment program or control group receiving education material about depression in digital form.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
800
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Mari Berglund
- Phone Number: +358 504427185
- Email: mari.berglund@utu.fi
Study Contact Backup
- Name: Tiia Ståhlberg
- Phone Number: 0504381160
- Email: tthuht@utu.fi
Study Locations
-
-
-
Turku, Finland
- Recruiting
- University of Turku
-
Contact:
- Mari Berglund
- Phone Number: +358 504427185
- Email: mari.berglund@utu.fi
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- fluent in written and spoken Finnish or Swedish
- access to computer or mobile phone with internet
- between 12 and 22 weeks pregnant
- screening and baseline score on the EPDS ≥10 points
Exclusion Criteria:
- lifetime history of psychotic disorder (e.g. schizophrenia, schizoaffective disorder, bipolar disorder, psychotic depression)
- active suicidal ideation
- severe substance abuse or dependence
- actively ongoing psychotherapy
- participates in another intervention study aiming at treating the symptoms of antenatal depression
- multiple pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Digitalized CBT intervention with phone coaching
Participants receive weekly sessions of internet-based CBT, including telephone coaching
|
Digitally delivered CBT intervention with weekly phone coaching
|
Active Comparator: Psychoeducation about depression
Participants receive psychoeducative material about depression in digitalized form.
|
Psychoeducational material about depression in a digitalized form
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in the Edinburgh Postnatal Depression Scale (EPDS)
Time Frame: Baseline and 11 weeks after randomization
|
EPDS is a ten-item self-report questionnaire originally developed to screen for postpartum depression.
The respondents are asked about the symptoms of depression.
The total score ranges from 0 to 30.
|
Baseline and 11 weeks after randomization
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in the General Anxiety Disorder 7-item scale (GAD-7)
Time Frame: Baseline and 11 weeks after randomization
|
To assess the change in anxiety symptoms from baseline to follow-up, we will use the Generalized Anxiety Disorder 7-item Scale (GAD-7) (Spitzer, Kroenke, Williams, & Löwe, 2006), which is a brief screening measure including seven items asking about anxiety symptoms experienced in the previous two weeks.
|
Baseline and 11 weeks after randomization
|
Change in the Beck Depression Inventory II (BDI-II)
Time Frame: Baseline and 11 weeks after randomization
|
To assess the change in depressive symptoms BDI-II will be used.
|
Baseline and 11 weeks after randomization
|
Social Phobia Inventory (SPIN)
Time Frame: Baseline and 11 weeks after randomization
|
To assess the change in Social Phobia SPIN will be used
|
Baseline and 11 weeks after randomization
|
Pregnancy-Related Anxiety Questionnaire-Revised (PRAQ)
Time Frame: Baseline and 11 weeks after randomization
|
To assess the change in pregnancy related anxiety PRAQ will be used
|
Baseline and 11 weeks after randomization
|
Perceived Stress Scale (PSS)
Time Frame: Baseline and 11 weeks after randomization
|
To assess the change in perceived stress PSS will be used
|
Baseline and 11 weeks after randomization
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Andre Sourander, Professor, University of Turku, Research Center for Child Psychiatry
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 10, 2021
Primary Completion (Estimated)
December 1, 2024
Study Completion (Estimated)
June 1, 2026
Study Registration Dates
First Submitted
January 7, 2020
First Submitted That Met QC Criteria
January 7, 2020
First Posted (Actual)
January 10, 2020
Study Record Updates
Last Update Posted (Actual)
February 20, 2024
Last Update Submitted That Met QC Criteria
February 16, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DEPMOM-2020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Lawson Health Research InstituteTerminated
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
Clinical Trials on Digitalized CBT with phone coaching
-
Linkoeping UniversityUnknown
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
University of IowaUS Department of Veterans AffairsActive, not recruitingPostpartum Depression | Perinatal DepressionUnited States
-
University of VirginiaUnknownDepression | Anxiety | Mental Health Wellness 1United States
-
Dr. Nazanin AlaviRecruiting
-
Utah State UniversityCompletedTreatment AdherenceUnited States
-
The Miriam HospitalCompleted
-
Dr. Nazanin AlaviActive, not recruitingGeneralized Anxiety Disorder | AnxietyCanada
-
National Cancer Center, KoreaRecruitingStage I Gastric CancerKorea, Republic of
-
Beacon Health SystemBeacon Health Foundation; Coach Me HealthActive, not recruitingType2 DiabetesUnited States